Amunix Pharmaceuticals, Inc.
Total Funding
$117 Million
Total Rounds
1
First Raise
Mar 8, 2021
Latest Raise
Mar 8, 2021
Organization Chart
Founders and leadership hierarchy for this company.
Contact details require Sales or Enterprise
All Funding Rounds
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 3/8/2021 | Series B | $117 Million | Viking Global Investors |
Company Performance Metrics
Premium Feature
Upgrade to Premium to view Capital Momentum Score and performance metrics